Biomedical Engineering Reference
In-Depth Information
13. Yang, S.X.,
Akt phosphorylation at Ser473 predicts benefit of
paclitaxel chemotherapy in node-positive breast cancer.
et al.
J Clin Oncol
, 2974-2981 (2010).
14. Paik, S.,
28
Gene expression and benefit of chemotherapy in women
with node-negative, estrogen receptor-positive breast cancer.
et al.
J Clin
, 3726-3734 (2006).
15. van Kuilenburg, A.B. Dihydropyrimidine dehydrogenase and the
efficacy and toxicity of 5-fluorouracil.
Oncol
24
Eur J Cancer
40
, 939-950
(2004).
16. Ciccolini, J.,
A rapid and inexpensive method for anticipating
severe toxicity to fluorouracil and fluorouracil-based chemotherapy.
Ther Drug Monit
et al.
28
, 678-685 (2006).
17. Innocenti, F.,
Genetic variants in the UDP-glucuronosyltransferase
1A1 gene predict the risk of severe neutropenia of irinotecan.
et al.
J Clin
, 1382-1388 (2004).
MedWatch/SafetyInformation/ucm215480.htm.
19. Ford, L.T., and Berg, J.D. Thiopurine S-methyltransferase (TPMT)
assessment prior to starting thiopurine drug treatment; a
pharmacogenomic test whose time has come.
Oncol
22
J Clin Pathol
63
, 288-
295 (2010).
20. Evans, W.E.,
Preponderance of thiopurine S-methyltransferase
deficiency and heterozygosity among patients intolerant to
mercaptopurine or azathioprine.
et al.
, 2293-2301 (2001).
21. Hait, W.N., and Hambley, T.W. Targeted cancer therapeutics.
J Clin Oncol
19
Cancer Res
, 1263-1267; discussion 1267 (2009).
22. Higgins, M.J., and Baselga, J. Breast cancer in 2010: Novel targets and
therapies for a personalized approach.
69
Nat Rev Clin Oncol
8
, 65-66
(2011).
23. Chau, C.H., Rixe, O., McLeod, H., and Figg, W.D. Validation of analytic
methods for biomarkers used in drug development.
Clin Cancer Res
14
,
5967-5976 (2008).
24. Wolff, A.C.,
American society of clinical oncology/college of
american pathologists guideline recommendations for human
epidermal growth factor receptor 2 testing in breast cancer.
et al.
Arch
, 18-43 (2007).
25. Hammond, M.E., Hayes, D.F., Wolff, A.C., Mangu, P.B., and Temin, S.
American society of clinical oncology/college of american pathologists
guideline recommendations for immunohistochemical testing of
Pathol Lab Med
131
